Wells Fargo & Company Deciphera Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.58 - $17.36 $31,614 - $40,414	2,328 Added 14.94%	17,910 $281,000
Q4 2023 Feb 09, 2024	SELL	$10.11 - $16.54 $221,803 - $362,871	-21,939 Reduced 58.47%	15,582 $251,000
Q3 2023 Nov 13, 2023	SELL	$12.46 - $15.48 $275,141 - $341,829	-22,082 Reduced 37.05%	37,521 $477,000
Q2 2023 Aug 15, 2023	BUY	$13.28 - $15.96 $148,908 - $178,959	11,213 Added 23.17%	59,603 $839,000
Q1 2023 May 12, 2023	BUY	$14.26 - $22.1 $690,041 - $1.07 Million	48,390 New	48,390 $747,000
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $9,445 - $15,435	-763 Reduced 32.1%	1,614 $30,000
Q2 2022 Aug 12, 2022	SELL	$9.11 - $13.98 $149,804 - $229,887	-16,444 Reduced 87.37%	2,377 $31,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $78,908 - $127,609	-11,486 Reduced 37.9%	18,821 $174,000
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $298,105 - $1.44 Million	-38,715 Reduced 56.09%	30,307 $296,000
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $3.89 Million - $5.46 Million	-147,092 Reduced 68.06%	69,022 $2.35 Million
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $10.9 Million - $16 Million	-332,876 Reduced 60.63%	216,114 $7.91 Million
Q1 2021 May 13, 2021	SELL	$40.39 - $56.73 $6.2 Million - $8.7 Million	-153,397 Reduced 21.84%	548,990 $24.6 Million
Q4 2020 Feb 09, 2021	BUY	$51.77 - $66.18 $9.58 Million - $12.2 Million	185,093 Added 35.78%	702,387 $40.1 Million
Q3 2020 Nov 05, 2020	BUY	$43.8 - $58.16 $834,740 - $1.11 Million	19,058 Added 3.83%	517,294 $26.5 Million
Q2 2020 Aug 13, 2020	BUY	$37.05 - $65.03 $1.22 Million - $2.13 Million	32,810 Added 7.05%	498,236 $29.8 Million
Q1 2020 May 14, 2020	BUY	$33.63 - $69.4 $15.7 Million - $32.3 Million	465,426 New	465,426 $19.2 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account